Hamid Hamzeiy

1.3k total citations
15 papers, 396 citations indexed

About

Hamid Hamzeiy is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Hamid Hamzeiy has authored 15 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Hamid Hamzeiy's work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Hamid Hamzeiy is often cited by papers focused on MicroRNA in disease regulation (6 papers), RNA modifications and cancer (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Hamid Hamzeiy collaborates with scholars based in Türkiye, Germany and Iran. Hamid Hamzeiy's co-authors include Jens Allmer, Malik Yousef, Müşerref Duygu Saçar Demirci, Jürgen Cox, Stefan Tenzer, Stephanie Kaspar‐Schoenefeld, Daniel N. Itzhak, Nagarjuna Nagaraj, Jan Daniel Rudolph and Sean J. Humphrey and has published in prestigious journals such as Nature Biotechnology, Current Opinion in Biotechnology and Neurobiology of Disease.

In The Last Decade

Hamid Hamzeiy

14 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hamid Hamzeiy Türkiye	10	295	118	116	33	31	15	396
Maroof K. Zafar United States	13	392 1.3×	17 0.1×	74 0.6×	3 0.1×	21 0.7×	23	473
Kathrin Oehl Switzerland	10	107 0.4×	19 0.2×	23 0.2×	8 0.2×	36 1.2×	10	254
Hana L. Goldschmidt United States	8	340 1.2×	15 0.1×	24 0.2×	7 0.2×	22 0.7×	12	442
Andrew M. Page United States	6	510 1.7×	73 0.6×	21 0.2×	4 0.1×	6 0.2×	7	587
Clare Jelinska United Kingdom	8	600 2.0×	13 0.1×	42 0.4×	3 0.1×	14 0.5×	12	689
Monika I. Linder Germany	7	247 0.8×	32 0.3×	8 0.1×	23 0.7×	12 0.4×	11	398
Pelagia Kyriakidou Germany	3	198 0.7×	59 0.5×	26 0.2×	2 0.1×	13 0.4×	4	300
David Comartin Canada	4	451 1.5×	30 0.3×	22 0.2×	4 0.1×	10 0.3×	4	578
Leonid Serebryannyy United States	13	352 1.2×	27 0.2×	12 0.1×	3 0.1×	17 0.5×	19	462
Isha Nasa United States	14	458 1.6×	25 0.2×	39 0.3×	2 0.1×	4 0.1×	23	566

Countries citing papers authored by Hamid Hamzeiy

Since Specialization

Citations

This map shows the geographic impact of Hamid Hamzeiy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Hamzeiy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Hamzeiy more than expected).

Fields of papers citing papers by Hamid Hamzeiy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Hamzeiy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Hamzeiy. The network helps show where Hamid Hamzeiy may publish in the future.

Co-authorship network of co-authors of Hamid Hamzeiy

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Hamzeiy. A scholar is included among the top collaborators of Hamid Hamzeiy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Hamzeiy. Hamid Hamzeiy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hamzeiy, Hamid, et al.. (2022). Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). Bioimpacts. 13(3). 183–190.

Hamzeiy, Hamid, et al.. (2022). Perseus plugin “Metis” for metabolic-pathway-centered quantitative multi-omics data analysis for static and time-series experimental designs. Cell Reports Methods. 2(4). 100198–100198. 3 indexed citations

Sinitcyn, Pavel, Hamid Hamzeiy, Daniel N. Itzhak, et al.. (2021). MaxDIA enables library-based and library-free data-independent acquisition proteomics. Nature Biotechnology. 39(12). 1563–1573. 156 indexed citations

Hamzeiy, Hamid, et al.. (2021). Genetic basis of acephalic spermatozoa syndrome, and intracytoplasmic sperm injection outcomes in infertile men: a systematic scoping review. Journal of Assisted Reproduction and Genetics. 38(3). 573–586. 11 indexed citations

Bahmanpour, Zahra, et al.. (2020). MicroRNAs association with azoospermia, oligospermia, asthenozoospermia, and teratozoospermia: a systematic review. Journal of Assisted Reproduction and Genetics. 37(4). 763–775. 40 indexed citations

Khabbazi, Alireza, et al.. (2020). A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran. Immunology Letters. 221. 27–32. 7 indexed citations

Corrado, Lucia, Cinzia Tiloca, Alessandra Bagarotti, et al.. (2018). Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 19(5-6). 426–431. 2 indexed citations

Hamzeiy, Hamid, Ceren Tunca, Daniela Calini, et al.. (2018). Elevated Global DNA Methylation Is Not Exclusive to Amyotrophic Lateral Sclerosis and Is Also Observed in Spinocerebellar Ataxia Types 1 and 2. Neurodegenerative Diseases. 18(1). 38–48. 23 indexed citations

Hamzeiy, Hamid, et al.. (2018). Visualization and Analysis of miRNAs Implicated in Amyotrophic Lateral Sclerosis Within Gene Regulatory Pathways. Studies in health technology and informatics. 253. 183–187. 9 indexed citations

10.

Hamzeiy, Hamid, et al.. (2017). Visualization and Analysis of MicroRNAs within KEGG Pathways using VANESA. Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics. 14(1). 15 indexed citations

11.

Gispert, Suzana, Sylvia Torres-Odio, Ewa Damrath, et al.. (2016). Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels. Neurobiology of Disease. 96. 115–126. 29 indexed citations

12.

Hamzeiy, Hamid & Jürgen Cox. (2016). What computational non-targeted mass spectrometry-based metabolomics can gain from shotgun proteomics. Current Opinion in Biotechnology. 43. 141–146. 6 indexed citations

13.

Demirci, Müşerref Duygu Saçar, Hamid Hamzeiy, & Jens Allmer. (2013). Can MiRBase Provide Positive Data for Machine Learning for the Detection of MiRNA Hairpins?. PubMed. 10(2). 215–215. 26 indexed citations

14.

Hamzeiy, Hamid, Jens Allmer, & Malik Yousef. (2013). Computational Methods for MicroRNA Target Prediction. Methods in molecular biology. 1107. 207–221. 49 indexed citations

15.

Demirci, Müşerref Duygu Saçar, Hamid Hamzeiy, & Jens Allmer. (2013). Can MiRBase Provide Positive Data for Machine Learning for the Detection of MiRNA Hairpins?. Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics. 10(2). 1–11. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact